2-MDP

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
2-MDP
2-MDP.svg
Systematic (IUPAC) name
3-amino-2-methyl-1,1-di(phenyl)propan-1-ol
Clinical data
Legal status
  • Legal
Identifiers
CAS Number 33887-05-7
PubChem CID: 26538
ChemSpider 24719 YesY
Chemical data
Formula C16H19NO
Molecular mass 241.33 g·mol−1
  • OC(c1ccccc1)(c2ccccc2)C(C)CN
  • InChI=1S/C16H19NO/c1-13(12-17)16(18,14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,13,18H,12,17H2,1H3 YesY
  • Key:XGYCHIPEPHYUIH-UHFFFAOYSA-N YesY
  (verify)

2-MDP (U-23807A) is a dissociative anaesthetic drug which has been found to be an NMDA antagonist and produces similar effects to PCP in animals. The levo or (-) isomer is the active form of the drug.[1][2] It also has stimulant effects, having only around one third the potency of amphetamine by weight, but with a long duration of action, lasting more than 24 hours from a single oral dose.[3]

References

  1. Tang AH, Cangelosi AA, Code RA, Franklin SR. Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP). Pharmacology, Biochemistry and Behaviour. 1984 Feb;20(2):209-13.
  2. Blake JC, Davies SN, Church J, Martin D, Lodge D. 2-Methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA). Pharmacology, Biochemistry and Behaviour. 1986 Jan;24(1):23-5.
  3. John H Biel. Annual Reports in Medicinal Chemistry, Volume 2. Academic Press 1966. p18.


<templatestyles src="Asbox/styles.css"></templatestyles>